Loading…
Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension
Heat-shock proteins protect cells from damage but are also often the target of immune responses in inflammation and may therefore both induce and perpetuate the chronic inflammation characterizing atherosclerosis. Hypertension is a well-established risk factor for atherosclerosis, and recently, bord...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 1997-01, Vol.29 (1), p.40-44 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3 |
container_end_page | 44 |
container_issue | 1 |
container_start_page | 40 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 29 |
creator | Frostegard, Johan Lemne, Carola Andersson, Birger van der Zee, Ruurd Kiessling, Rolf Faire, Ulf de |
description | Heat-shock proteins protect cells from damage but are also often the target of immune responses in inflammation and may therefore both induce and perpetuate the chronic inflammation characterizing atherosclerosis. Hypertension is a well-established risk factor for atherosclerosis, and recently, borderline hypertension also has been related to atherosclerosis. The present study investigated the possible role of heat-shock proteins in borderline hypertension and their relation to atherosclerosis by investigating antibody titers against the 65-kD heat-shock protein (HSP65). Sixty-six men with borderline hypertension and 67 age-matched normotensive men (diastolic pressure, 85 to 94 and < 80 mm Hg, respectively) were recruited from a population screening program. Titers of antibodies to HSP65 were determined by enzyme-linked immunosorbent assay. The presence of carotid atherosclerosis was determined by B-mode ultrasonography. Twenty-seven individuals had atherosclerotic plaques; 48 were smokers (more than one to two cigarettes per day). Borderline hypertensive men had higher anti-HSP65 reactivity than normotensive control subjects (P = .034). Smokers with atherosclerosis had low levels of antibodies to HSP65 compared with nonsmokers with atherosclerosis (P = .002). Furthermore, when high-risk individuals (borderline hypertension plus plaque, n = 15) were compared with matched low-risk individuals (normotensive with no plaque, n = 15), the high-risk men had significantly enhanced antibody titers to HSP65 (P = .041). In conclusion, we demonstrate that serum antibody titers to HSP65 are enhanced in individuals with borderline hypertension, which may indicate an ongoing immune reaction in the artery wall. (Hypertension. 1997;29:40-44.) |
doi_str_mv | 10.1161/01.HYP.29.1.40 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_438930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29062633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3</originalsourceid><addsrcrecordid>eNpdkcGL1DAUxoso67h69SYEEW-teU2aNMdxUUdYcGFd1FNI01cmO51mTFKG_e_NMGUO5pK893583wtfUbwFWgEI-ESh2vy5q2pVQcXps2IFTc1L3gj2vFhRULxUAL9fFq9ifKQUOOfyqrhSlCkq5ap4WMforTPJ-Yn4gdxjmPdkPSXX-d5hJMmTDZpU3m-93ZG74BO6iYiG_HJpSz770GMY3YRk83TAkHCKWel18WIwY8Q3y31dPHz98vNmU97--Pb9Zn1b2oYqUaLsQPKh66SoWW8VUFab3rSdQiqMtYzBwHmPDBhnvZG8lxxhoKZrWyFNx66L8qwbj3iYO30Ibm_Ck_bG6aW1yy_UnLWK0cx_PPOH4P_OGJPeu2hxHM2Efo5ati0TjeAZfP8f-OjnMOW_6Jo2dUuZZBmqzpANPsaAw8UfqD6FoynoHI6ulQbNT_bvFtW522N_wZc08vzDMjfRmnEIZrIuXrC6kVzw03L8jB39mDDE3TgfMegtmjFtNc2H16ItQSlJIVflqSXYPyRtpi4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205280373</pqid></control><display><type>article</type><title>Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension</title><source>EZB Electronic Journals Library</source><creator>Frostegard, Johan ; Lemne, Carola ; Andersson, Birger ; van der Zee, Ruurd ; Kiessling, Rolf ; Faire, Ulf de</creator><creatorcontrib>Frostegard, Johan ; Lemne, Carola ; Andersson, Birger ; van der Zee, Ruurd ; Kiessling, Rolf ; Faire, Ulf de</creatorcontrib><description>Heat-shock proteins protect cells from damage but are also often the target of immune responses in inflammation and may therefore both induce and perpetuate the chronic inflammation characterizing atherosclerosis. Hypertension is a well-established risk factor for atherosclerosis, and recently, borderline hypertension also has been related to atherosclerosis. The present study investigated the possible role of heat-shock proteins in borderline hypertension and their relation to atherosclerosis by investigating antibody titers against the 65-kD heat-shock protein (HSP65). Sixty-six men with borderline hypertension and 67 age-matched normotensive men (diastolic pressure, 85 to 94 and < 80 mm Hg, respectively) were recruited from a population screening program. Titers of antibodies to HSP65 were determined by enzyme-linked immunosorbent assay. The presence of carotid atherosclerosis was determined by B-mode ultrasonography. Twenty-seven individuals had atherosclerotic plaques; 48 were smokers (more than one to two cigarettes per day). Borderline hypertensive men had higher anti-HSP65 reactivity than normotensive control subjects (P = .034). Smokers with atherosclerosis had low levels of antibodies to HSP65 compared with nonsmokers with atherosclerosis (P = .002). Furthermore, when high-risk individuals (borderline hypertension plus plaque, n = 15) were compared with matched low-risk individuals (normotensive with no plaque, n = 15), the high-risk men had significantly enhanced antibody titers to HSP65 (P = .041). In conclusion, we demonstrate that serum antibody titers to HSP65 are enhanced in individuals with borderline hypertension, which may indicate an ongoing immune reaction in the artery wall. (Hypertension. 1997;29:40-44.)</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.29.1.40</identifier><identifier>PMID: 9039077</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Adult ; Antibodies - blood ; Arterial hypertension. Arterial hypotension ; Arteriosclerosis - diagnostic imaging ; Arteriosclerosis - etiology ; Arteriosclerosis - immunology ; Bacterial Proteins ; Biological and medical sciences ; Blood and lymphatic vessels ; Body Constitution ; Cardiology. Vascular system ; Carotid Arteries - diagnostic imaging ; Carotid Arteries - pathology ; Case-Control Studies ; Chaperonin 60 ; Chaperonins - immunology ; Clinical manifestations. Epidemiology. Investigative techniques. Etiology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Hyperinsulinism - complications ; Hyperlipidemias - complications ; Hypertension - blood ; Hypertension - complications ; Hypertension - immunology ; Male ; Medical sciences ; Middle Aged ; Risk Factors ; Smoking - immunology ; Ultrasonography</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1997-01, Vol.29 (1), p.40-44</ispartof><rights>1997 American Heart Association, Inc.</rights><rights>1997 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Jan 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3</citedby><cites>FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2574644$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9039077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1956490$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Frostegard, Johan</creatorcontrib><creatorcontrib>Lemne, Carola</creatorcontrib><creatorcontrib>Andersson, Birger</creatorcontrib><creatorcontrib>van der Zee, Ruurd</creatorcontrib><creatorcontrib>Kiessling, Rolf</creatorcontrib><creatorcontrib>Faire, Ulf de</creatorcontrib><title>Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Heat-shock proteins protect cells from damage but are also often the target of immune responses in inflammation and may therefore both induce and perpetuate the chronic inflammation characterizing atherosclerosis. Hypertension is a well-established risk factor for atherosclerosis, and recently, borderline hypertension also has been related to atherosclerosis. The present study investigated the possible role of heat-shock proteins in borderline hypertension and their relation to atherosclerosis by investigating antibody titers against the 65-kD heat-shock protein (HSP65). Sixty-six men with borderline hypertension and 67 age-matched normotensive men (diastolic pressure, 85 to 94 and < 80 mm Hg, respectively) were recruited from a population screening program. Titers of antibodies to HSP65 were determined by enzyme-linked immunosorbent assay. The presence of carotid atherosclerosis was determined by B-mode ultrasonography. Twenty-seven individuals had atherosclerotic plaques; 48 were smokers (more than one to two cigarettes per day). Borderline hypertensive men had higher anti-HSP65 reactivity than normotensive control subjects (P = .034). Smokers with atherosclerosis had low levels of antibodies to HSP65 compared with nonsmokers with atherosclerosis (P = .002). Furthermore, when high-risk individuals (borderline hypertension plus plaque, n = 15) were compared with matched low-risk individuals (normotensive with no plaque, n = 15), the high-risk men had significantly enhanced antibody titers to HSP65 (P = .041). In conclusion, we demonstrate that serum antibody titers to HSP65 are enhanced in individuals with borderline hypertension, which may indicate an ongoing immune reaction in the artery wall. (Hypertension. 1997;29:40-44.)</description><subject>Adult</subject><subject>Antibodies - blood</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Arteriosclerosis - diagnostic imaging</subject><subject>Arteriosclerosis - etiology</subject><subject>Arteriosclerosis - immunology</subject><subject>Bacterial Proteins</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Body Constitution</subject><subject>Cardiology. Vascular system</subject><subject>Carotid Arteries - diagnostic imaging</subject><subject>Carotid Arteries - pathology</subject><subject>Case-Control Studies</subject><subject>Chaperonin 60</subject><subject>Chaperonins - immunology</subject><subject>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Humans</subject><subject>Hyperinsulinism - complications</subject><subject>Hyperlipidemias - complications</subject><subject>Hypertension - blood</subject><subject>Hypertension - complications</subject><subject>Hypertension - immunology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Risk Factors</subject><subject>Smoking - immunology</subject><subject>Ultrasonography</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpdkcGL1DAUxoso67h69SYEEW-teU2aNMdxUUdYcGFd1FNI01cmO51mTFKG_e_NMGUO5pK893583wtfUbwFWgEI-ESh2vy5q2pVQcXps2IFTc1L3gj2vFhRULxUAL9fFq9ifKQUOOfyqrhSlCkq5ap4WMforTPJ-Yn4gdxjmPdkPSXX-d5hJMmTDZpU3m-93ZG74BO6iYiG_HJpSz770GMY3YRk83TAkHCKWel18WIwY8Q3y31dPHz98vNmU97--Pb9Zn1b2oYqUaLsQPKh66SoWW8VUFab3rSdQiqMtYzBwHmPDBhnvZG8lxxhoKZrWyFNx66L8qwbj3iYO30Ibm_Ck_bG6aW1yy_UnLWK0cx_PPOH4P_OGJPeu2hxHM2Efo5ati0TjeAZfP8f-OjnMOW_6Jo2dUuZZBmqzpANPsaAw8UfqD6FoynoHI6ulQbNT_bvFtW522N_wZc08vzDMjfRmnEIZrIuXrC6kVzw03L8jB39mDDE3TgfMegtmjFtNc2H16ItQSlJIVflqSXYPyRtpi4</recordid><startdate>199701</startdate><enddate>199701</enddate><creator>Frostegard, Johan</creator><creator>Lemne, Carola</creator><creator>Andersson, Birger</creator><creator>van der Zee, Ruurd</creator><creator>Kiessling, Rolf</creator><creator>Faire, Ulf de</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>199701</creationdate><title>Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension</title><author>Frostegard, Johan ; Lemne, Carola ; Andersson, Birger ; van der Zee, Ruurd ; Kiessling, Rolf ; Faire, Ulf de</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Antibodies - blood</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Arteriosclerosis - diagnostic imaging</topic><topic>Arteriosclerosis - etiology</topic><topic>Arteriosclerosis - immunology</topic><topic>Bacterial Proteins</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Body Constitution</topic><topic>Cardiology. Vascular system</topic><topic>Carotid Arteries - diagnostic imaging</topic><topic>Carotid Arteries - pathology</topic><topic>Case-Control Studies</topic><topic>Chaperonin 60</topic><topic>Chaperonins - immunology</topic><topic>Clinical manifestations. Epidemiology. Investigative techniques. Etiology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Humans</topic><topic>Hyperinsulinism - complications</topic><topic>Hyperlipidemias - complications</topic><topic>Hypertension - blood</topic><topic>Hypertension - complications</topic><topic>Hypertension - immunology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Risk Factors</topic><topic>Smoking - immunology</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frostegard, Johan</creatorcontrib><creatorcontrib>Lemne, Carola</creatorcontrib><creatorcontrib>Andersson, Birger</creatorcontrib><creatorcontrib>van der Zee, Ruurd</creatorcontrib><creatorcontrib>Kiessling, Rolf</creatorcontrib><creatorcontrib>Faire, Ulf de</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frostegard, Johan</au><au>Lemne, Carola</au><au>Andersson, Birger</au><au>van der Zee, Ruurd</au><au>Kiessling, Rolf</au><au>Faire, Ulf de</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1997-01</date><risdate>1997</risdate><volume>29</volume><issue>1</issue><spage>40</spage><epage>44</epage><pages>40-44</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Heat-shock proteins protect cells from damage but are also often the target of immune responses in inflammation and may therefore both induce and perpetuate the chronic inflammation characterizing atherosclerosis. Hypertension is a well-established risk factor for atherosclerosis, and recently, borderline hypertension also has been related to atherosclerosis. The present study investigated the possible role of heat-shock proteins in borderline hypertension and their relation to atherosclerosis by investigating antibody titers against the 65-kD heat-shock protein (HSP65). Sixty-six men with borderline hypertension and 67 age-matched normotensive men (diastolic pressure, 85 to 94 and < 80 mm Hg, respectively) were recruited from a population screening program. Titers of antibodies to HSP65 were determined by enzyme-linked immunosorbent assay. The presence of carotid atherosclerosis was determined by B-mode ultrasonography. Twenty-seven individuals had atherosclerotic plaques; 48 were smokers (more than one to two cigarettes per day). Borderline hypertensive men had higher anti-HSP65 reactivity than normotensive control subjects (P = .034). Smokers with atherosclerosis had low levels of antibodies to HSP65 compared with nonsmokers with atherosclerosis (P = .002). Furthermore, when high-risk individuals (borderline hypertension plus plaque, n = 15) were compared with matched low-risk individuals (normotensive with no plaque, n = 15), the high-risk men had significantly enhanced antibody titers to HSP65 (P = .041). In conclusion, we demonstrate that serum antibody titers to HSP65 are enhanced in individuals with borderline hypertension, which may indicate an ongoing immune reaction in the artery wall. (Hypertension. 1997;29:40-44.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9039077</pmid><doi>10.1161/01.HYP.29.1.40</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 1997-01, Vol.29 (1), p.40-44 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_438930 |
source | EZB Electronic Journals Library |
subjects | Adult Antibodies - blood Arterial hypertension. Arterial hypotension Arteriosclerosis - diagnostic imaging Arteriosclerosis - etiology Arteriosclerosis - immunology Bacterial Proteins Biological and medical sciences Blood and lymphatic vessels Body Constitution Cardiology. Vascular system Carotid Arteries - diagnostic imaging Carotid Arteries - pathology Case-Control Studies Chaperonin 60 Chaperonins - immunology Clinical manifestations. Epidemiology. Investigative techniques. Etiology Enzyme-Linked Immunosorbent Assay Humans Hyperinsulinism - complications Hyperlipidemias - complications Hypertension - blood Hypertension - complications Hypertension - immunology Male Medical sciences Middle Aged Risk Factors Smoking - immunology Ultrasonography |
title | Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T14%3A04%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Serum%20Antibodies%20to%20Heat-Shock%20Protein%2065%20With%20Borderline%20Hypertension&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Frostegard,%20Johan&rft.date=1997-01&rft.volume=29&rft.issue=1&rft.spage=40&rft.epage=44&rft.pages=40-44&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.29.1.40&rft_dat=%3Cproquest_swepu%3E29062633%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5096-e7b174fbb7623dc91032ada8b9e06acc331f44de31343da74d74e1f0ab8867ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205280373&rft_id=info:pmid/9039077&rfr_iscdi=true |